v3.25.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash Flows From Operating Activities:    
Net loss $ (53,981) $ (206,470)
Net loss from discontinued operations 0 (860)
Net loss from continuing operations (53,981) (205,610)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 26,818 20,225
Share based compensation 22,141 19,677
Foreign currency remeasurement impact (2,165) 0
In-process research and development 0 65,205
Other (693) 5,350
Changes in operating assets and liabilities:    
Accounts receivable (11,486) (3,286)
Inventory 3,645 (3,240)
Prepaid expenses and other current and non-current assets (6,777) (1,858)
Accounts payable (5,223) (15,641)
Accrued expenses (8,200) (41,172)
Deferred revenue (2,815) (3,643)
Other current and non-current liabilities 1,525 5,157
Net cash used in operating activities - continuing operations (37,211) (158,836)
Net cash used in operating activities - discontinued operations 0 (412)
Net cash used in operating activities (37,211) (159,248)
Cash Flows From Investing Activities:    
Proceeds from the sale and maturity of marketable debt securities 134,553 216,967
Purchase of marketable debt securities (64,371) 0
Purchase of fixed assets (235) (82)
Purchase of intangible assets (23,870) (18,377)
Other 63 0
Payment of milestone 0 (65,000)
Net cash provided by investing activities 46,140 133,508
Cash Flows From Financing Activities:    
Payment of guaranteed minimum royalty (1,050) (1,050)
Proceeds from exercise of stock options 4,706 0
Proceeds from issuances under the employee stock purchase plan 1,537 1,307
Net cash provided by financing activities 5,193 257
Effect of exchange rate changes on cash 2,497 (402)
Net increase (decrease) in cash and cash equivalents 16,619 (25,885)
Cash and cash equivalents, beginning of year 58,535 58,176
Cash and cash equivalents, end of period $ 75,154 $ 32,291